Replimune REPL
NASDAQ REPL
$15.04 -0.25 (-1.64%)
As of: Sep 4, 2026 · 3:59 PM EDT

Replimune (REPL) Other Working Capital Changes (2017 - 2026)

Replimune (REPL) posted Other Working Capital Changes of -$234000.0 for Q1 2026, down 25.81% sequentially from -$186000.0 in Q4 2025, and down 25.13% YoY from -$312557.1 in Q1 2025.

Analysis

Replimune (REPL) Other Working Capital Changes (2017 - 2026) Analysis & Trends

Replimune has reported Other Working Capital Changes for 7 years, with the latest figure at -$234000.0 in Q1 2026.

  • Quarterly Other Working Capital Changes fell 25.13% year-over-year to -$234000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$818000.0 (down 13.61% YoY) and the FY2026 annual result came in at -$818000.0, down 13.61% from the prior year.
  • Other Working Capital Changes eased to -$234000.0 in Q1 2026 per REPL's latest filing, from -$186000.0 in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.2 million in Q3 2024 and troughed at -$1.8 million in Q2 2024.
  • A 5-year average of $188352.9 and a median of $140000.0 in 2025 frame the typical range for Other Working Capital Changes.
  • The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 555.22% in 2023, then slumped 3016.67% in 2025.
  • Over 5 years, Other Working Capital Changes stood at -$134000.0 in 2022, then jumped by 555.22% to $610000.0 in 2023, then tumbled by 187.38% to -$533000.0 in 2024, then soared by 65.1% to -$186000.0 in 2025, then retreated by 25.81% to -$234000.0 in 2026.
  • According to Business Quant data, Other Working Capital Changes over the past three periods registered -$234000.0, -$186000.0, and -$82000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Replimune 1.46 Bn 1.46 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.13 Mn
Jun 30, 2026 -3.13 Mn
Mar 31, 2026 -213,000.00
Mar 31, 2026 -213,000.00
Dec 31, 2025 -207,000.00
Dec 31, 2025 -207,000.00
Sep 30, 2025 -82,000.00
Sep 30, 2025 -82,000.00
Jun 30, 2025 -316,000.00
Jun 30, 2025 -316,000.00
Mar 31, 2025 -187,000.00
Mar 31, 2025 -187,000.00
Dec 31, 2024 -940,000.00
Dec 31, 2024 -940,000.00
Sep 30, 2024 2.22 Mn
Sep 30, 2024 2.22 Mn
Jun 30, 2024 -1.82 Mn
Jun 30, 2024 -1.82 Mn
Mar 31, 2024 -433,000.00
Mar 31, 2024 -433,000.00